Handok-Teva’s strugglein the Korean pharmaceutical market

Published: 2014-11-24 15:07:21

Updated: 2014-11-24 15:30:10

It is analyzed that Handok-Teva, co-established by a domestic pharmaceutical company, Handok, and one of the top global pharmaceutical companies, Teva, an Israel comapany, has been suffering in the Korean pharmaceutical marketsince its establishment 2 years ago as it recorded financial damages worth of KRW 7.7 billion.

Handok co-invested funds with the top company in the global generic market,...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.